At a Glance
| Detail | Parambil | ProvaLens |
|---|---|---|
| Category | eDiscovery | eDiscovery |
| Total raised | $8M | Not disclosed |
| Rounds tracked | 2 | Not disclosed |
| Latest round | Seed, $6M · Jan 2026 | Not disclosed |
| Last valuation | Not disclosed | Not disclosed |
| Lead investors | Bling Capital, Daybreak Ventures | Not disclosed |
| Built for | Mid-size firms, Boutiques | Boutiques |
| Headquarters | United States | US |
Funding, Side by Side
Parambil rounds
- Jan 2026Seed$6M
- Jan 2025Seed$2M
ProvaLens rounds
No public rounds tracked yet.
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Parambil or ProvaLens?
- Parambil has raised $8M in disclosed funding, compared with no disclosed amount for ProvaLens.
- What is Parambil best for?
- Parambil is AI medical record review software for mass tort and complex litigation.
- What is ProvaLens best for?
- ProvaLens reads your case file and cites every page — demand packages, Potential Conflicts, cross-exam prep. Flat pricing. Works with Clio, MyCase.
Source: Legal Tech Circle funding data, from public announcements. Updated November 10, 2026.